RNA is more sensitive than DNA in identification of breast cancer patients bearing tumor nucleic acids in plasma [2]

Genes Chromosomes and Cancer

Volumn 35, Issue 4, 2002, Pages 375-376

  Silva, Javier ^a   Silva, Jose M ^a   García, Vanesa ^a   García, Jose M ^a   Domínguez, Gemma ^a   Bonilla, Félix ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19; DNA; MESSENGER RNA;

BLOOD; BREAST CANCER; HUMAN; LETTER; MICROSATELLITE MARKER; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

BREAST NEOPLASMS; DNA, NEOPLASM; EPITHELIAL CELLS; GENETIC MARKERS; HUMANS; MICROSATELLITE REPEATS; RNA, NEOPLASM; SEQUENCE ANALYSIS, DNA; TUMOR MARKERS, BIOLOGICAL;

EID: 0036883684     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10124     Document Type: Letter

References (14)

1. Anker P, Lefort F, Vasioukhin V, Lyautey J, Lederrey C, Chen XQ, Stroun M, Mulcahy HE, Farthing MJ. 1997. K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology 112:1114-1120.
2. Chen XQ, Stroun NI, Magnenat JL, Nicod LP, Kurt AM, Lyautey J, Lederrey C, Anker P. 1996. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 2:1033-1035.
3. Chen XQ, Bonnefoi H, Diebold-Berger S, Lyautey J, Lederrey C, Faltin-Traub E, Stroun M, Anker P. 1999. Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer. Clin Cancer Res 5:2297-2303.
4. Chen XQ, Bonnefoi H, Pelte MF, Lyautey J, Lederrey C, Movarekhi S, Schaeffer P, Mulcahy HE, Meyer P, Stroun M, Anker P. 2000. Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res 6:3823-3826.
5. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG. 1999. Detection of aberrant promoter hypemethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 59:67-70.
6. García JM, Silva JM, Dominguez G, Silva J, Bonilla F. 2001. Heterogeneous tumor clones as an explanation of discordance between plasma DNA and tumor DNA alteration. Genes Chromosomes Cancer 31:300-301.
7. González R, Silva JM, Sanchez A, Dominguez G, García JM, Chen XQ, Stroun M, Provencio M, España P, Anker P, Bonilla F. 2000. Microsatellite alteration and TP53 mutations in plasma DNA of small cell lung cancer patients: Follow-up study and prognostic significance. Ann Oncol 11:1097-1104.
8. Hibi K, Robinson CR, Booker S, Wu L, Hamilton SR, Sidransky D, Jen J. 1998. Molecular detection of genetic alterations in serum of colorectal cancer patients. Cancer Res 58:1405-1407.
9. Kopreski MS, Benko FA, Kwee C, Leitzel KE, Eskander E, Lipton A, Gocke CD. 1997. Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer. Br J Cancer 76:1293-1299.
10. Kopreski MS, Benko FA, Kwak LW, Gocke CD. 1999. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res 5:1962-1965.
11. Lo KW, Lo YM, Leung SF, Tsang YS, Chan LY, Johnson PJ, Hjelm NM, Lee JC, Huang DP. 1999. Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinomas. Clin Chem 45:1292-1294.
12. Mayall F, Fairweather S, Wilkins R, Chang B, Nicholls R. 1999. Microsatellite abnormalities in plasma of patients with breast carcinomas: Concordances with the primary tumor. J Clin Pathol 52:363-366.
13. Silva JM, Dominguez G, García JM, González R, Villanueva MJ, Navarro F, Provencio M, San Martin S, España P, Bonilla F. 1999. Presence of tumor DNA in plasma of breast cancer patients: Clinicopathological correlations. Cancer Res 59:3251-3256.
14. Silva JM, Dominguez G, Silva J, García JM, Sanchez A, Rodriguez O, Provencio M, España P, Bonilla F. 2001. Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin Cancer Res 7:2821-2825.